InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,046.00
-65.00 (-5.85%)
Nov 6, 2026, 1:47 PM IST
InterCure Market Cap
InterCure has a market cap or net worth of 123.91 million as of November 6, 2026. It is the 31,717th most valuable company in the world and the 358th biggest in Israel. Its market cap has decreased by 50.45% in one year.
Market Cap
123.91M
Enterprise Value
260.08M
Revenue
270.20M
Global Rank
Country Rank
#358 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.36M to 123.91M, an increase of 1,847.49%. That is a compound annual growth rate of 20.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 123.91M | -29.98% |
| Dec 31, 2025 | 176.95M | -34.89% |
| Dec 31, 2024 | 271.76M | 28.77% |
| Dec 31, 2023 | 211.05M | -61.66% |
| Dec 29, 2022 | 550.52M | -40.95% |
| Dec 30, 2021 | 932.28M | 111.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.37B |
| Amal Holdings A.D. | 2.10B |
| Rafa Laboratories | 1.69B |
| Bait Bakfar | 1.41B |
| Bonus BioGroup | 184.57M |
| Golden House | 161.84M |
| Rekah Pharmaceutical Industry | 115.86M |
| Epitomee Medical | 86.73M |